Informax Inc.

News & Analysis

informax inc. - All News and Analysis

• Research and Markets: InforMax Inc. - Company Profile Calculates Its Top 5 Competitors According to Sales, Profit, Number of Employees and Market Cap

  - 2007-02-28

  DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c51250) has announced the addition of InforMax Inc. - Company Profile to their offering. This Company Profile will assist individual investors, managers and companies in evaluating opportunities, trends and market innovations and in selecting appropriate information solutions in order to make effective decisions....

  Tags: Informax Inc.

• InforMax, Inc.(INMX) - Quantitative Valuation Report.

  - 2003-03-03

  M2 PRESSWIRE-3 March 2003-Research and Markets: InforMax, Inc.INMX - Quantitative Valuation ReportC1994-2003 M2 COMMUNICATIONS LTD RDATE:03022003 Company Name - InforMax, Inc. Now you, as an individual investor or investment professional, can have access to the same tools used...

  Tags: Informax Inc.

• Invitrogen Announces Close of Subsequent Offering Period in Its Cash Tender Offer for InforMax Inc

  - 2002-12-05

  Business Editors & Health/Medical Writers BIOWIRE2K SAN DIEGO--BUSINESS WIRE--Dec. 5, 2002 Invitrogen Corp. (Nasdaq:IVGN) announced today the completion of the cash tender offer by Babcock Inc., a wholly owned subsidiary of Invitrogen Corp., for all outstanding shares of common stock of InforMax Inc. (Nasdaq:INMX). The tender...

  Tags: Informax Inc.

• InforMax Announces Third Quarter Results

  - 2002-10-29

  Business Editors & Health/Medical Writers BIOWIRE2K BETHESDA, Md.--BUSINESS WIRE--Oct. 29, 2002 InforMax, Inc. (NASDAQ:INMX), a leading global provider of life science informatics solutions and services, today announced that for the third quarter ended September 30, 2002, it had revenue of $3.1 million, representing a 35% decrease compared...

  Tags: Informax Inc.

• Invitrogen Corp. to acquire InforMax Inc. for 1.67 times revenue

  - 2002-10-21

  The Deal: Invitrogen Corporation and InforMax Inc. have announced a definitive merger agreement under which Invitrogen will acquire InforMax in an all-cash transaction. Invitrogen will pay $1.36 per InforMax share, or approximately $42 million. The transaction will be conducted as a cash tender offer for all outstanding InforMax shares. The...

  Tags: Invitrogen Corp.

• Invitrogen acquires InforMax

  - 2002-10-15

  San Diego, CA and Bethesda, MD 10/15/02--Invitrogen has signed a definitive agreement to purchase bioinformatics company InforMax for approximately $42 million in a cash tender offer of $1.36 per share. Following the transaction, InforMax will become a wholly owned subsidiary with current InforMax and InforMax Chairman and CEO Andrew Whiteley...

  Tags: Informax Inc.

• Invitrogen to Acquire InforMax

  - 2002-10-15

  Business Editors & Health/Medical Writers BIOWIRE2K SAN DIEGO & BETHESDA, Md.--BUSINESS WIRE--Oct. 15, 2002 Invitrogen Corp. (Nasdaq:IVGN) and InforMax Inc. (Nasdaq:INMX) today announced a definitive agreement under which Invitrogen will acquire InforMax in an all-cash transaction valued at $1.36 per share, or approximately $42 million for the...

  Tags: Informax Inc.

• InforMax Announces Preliminary Third Quarter Results

  - 2002-10-15

  Business Editors & Health/Medical Writers BIOWIRE2K BETHESDA, Md.--BUSINESS WIRE--Oct. 15, 2002 InforMax, Inc., a leading global provider of life science informatics solutions and services, today announced that for the third quarter ended September 30, 2002, it expects revenue of $3.1 million, representing a 35% decrease compared to...

  Tags: Informax Inc.

• Invitrogen to Acquire InforMax

  - 2002-10-15

  Business Editors & Health/Medical Writers

  Tags: Invitrogen Corp.

• InforMax Announces Vector PathBlazer - A Powerful New Tool For Analysis of Biological Pathways And Protein-Protein Interactions

  - 2002-10-09

  Business Editors/Health & Medical Writers BIOWIRE2K BETHESDA, Md.--BUSINESS WIRE--Oct. 9, 2002 InforMax, Inc. (Nasdaq:INMX), a market leader providing life scientists with informatics software solutions and services, is introducing Vector PathBlazerTM, a new desktop application for the integration of diverse biological pathway and protein-protein interaction data. Vector...

  Tags: Informax Inc.